FDA's Expedited Drug Programs: Analysis, Postmarket Monitoring & Industry Guidance
Editat de Gary Lawrenceen Limba Engleză Paperback – sep 2016
Preț: 756.46 lei
Preț vechi: 881.62 lei
-14% Nou
Puncte Express: 1135
Preț estimativ în valută:
144.82€ • 150.53$ • 120.07£
144.82€ • 150.53$ • 120.07£
Carte disponibilă
Livrare economică 15-29 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781634857727
ISBN-10: 1634857720
Pagini: 100
Dimensiuni: 155 x 230 x 9 mm
Greutate: 0.19 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers Inc
ISBN-10: 1634857720
Pagini: 100
Dimensiuni: 155 x 230 x 9 mm
Greutate: 0.19 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers Inc
Cuprins
Preface; Drug Safety: FDA Expedites Many Applications, But Data for Postapproval Oversight Need Improvement; Statement of Janet Woodcock, Director, Center for Drug Evaluation & Research, Food & Drug Administration. Hearing on ''21st Century Cures: Incorporating the Patient Perspective''; Guidance for Industry: Expedited Programs for Serious Conditions Drugs & Biologics; Index.